To tell a friend about the AMARANTH Study, please complete the following:
The email content that will be sent to your friend is shown below:
<Referrer’s Name> has suggested that we tell you about a clinical research study for early Alzheimer’s disease. The AMARANTH Study will test the safety, tolerability and effects of an investigational drug on adults between 55 and 85 years old with mild Alzheimer’s disease or with mild cognitive impairment due to early Alzheimer’s disease. Please click here to learn more about the AMARANTH Study. After you review the study information, you will have the opportunity to complete a pre-qualification survey to determine if you may be eligible to participate in this clinical research study at a study center in your area. Thank you!